Nuveen Asset Management’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.92M | Hold |
178,965
| – | – | ﹤0.01% | 2406 |
|
|
2024
Q3 | $1.02M | Sell |
178,965
-125,200
| -41% | -$711K | ﹤0.01% | 2752 |
|
|
2024
Q2 | $1.28M | Buy |
304,165
+38,373
| +14% | +$162K | ﹤0.01% | 2604 |
|
|
2024
Q1 | $1.35M | Buy |
265,792
+25,351
| +11% | +$129K | ﹤0.01% | 2571 |
|
|
2023
Q4 | $2.24M | Buy |
240,441
+13,819
| +6% | +$129K | ﹤0.01% | 2362 |
|
|
2023
Q3 | $1.48M | Buy |
226,622
+14,155
| +7% | +$92.7K | ﹤0.01% | 2414 |
|
|
2023
Q2 | $1.73M | Buy |
212,467
+1,065
| +0.5% | +$8.66K | ﹤0.01% | 2406 |
|
|
2023
Q1 | $1.81M | Sell |
211,402
-9,678
| -4% | -$83K | ﹤0.01% | 2369 |
|
|
2022
Q4 | $2.05M | Sell |
221,080
-50,375
| -19% | -$467K | ﹤0.01% | 2380 |
|
|
2022
Q3 | $2.8M | Sell |
271,455
-3,575
| -1% | -$36.9K | ﹤0.01% | 2216 |
|
|
2022
Q2 | $2.75M | Buy |
275,030
+1,299
| +0.5% | +$13K | ﹤0.01% | 2275 |
|
|
2022
Q1 | $3.43M | Buy |
273,731
+29,603
| +12% | +$371K | ﹤0.01% | 2264 |
|
|
2021
Q4 | $4.23M | Buy |
244,128
+18,460
| +8% | +$320K | ﹤0.01% | 2220 |
|
|
2021
Q3 | $4.05M | Sell |
225,668
-9,150
| -4% | -$164K | ﹤0.01% | 2328 |
|
|
2021
Q2 | $5.37M | Sell |
234,818
-16,789
| -7% | -$384K | ﹤0.01% | 2203 |
|
|
2021
Q1 | $3.76M | Buy |
251,607
+49,915
| +25% | +$746K | ﹤0.01% | 2307 |
|
|
2020
Q4 | $1.09M | Buy |
201,692
+1,605
| +0.8% | +$8.67K | ﹤0.01% | 2772 |
|
|
2020
Q3 | $910K | Buy |
200,087
+909
| +0.5% | +$4.13K | ﹤0.01% | 2728 |
|
|
2020
Q2 | $980K | Sell |
199,178
-12,512
| -6% | -$61.6K | ﹤0.01% | 2633 |
|
|
2020
Q1 | $667K | Buy |
211,690
+101,495
| +92% | +$320K | ﹤0.01% | 2665 |
|
|
2019
Q4 | $285K | Hold |
110,195
| – | – | ﹤0.01% | 3024 |
|
|
2019
Q3 | $348K | Hold |
110,195
| – | – | ﹤0.01% | 3028 |
|
|
2019
Q2 | $372K | Buy |
+110,195
| New | +$372K | ﹤0.01% | 3073 |
|